Related Experiment Videos
Soft-tissue sarcoma involving bone or neurovascular structures: MR imaging prognostic factors
D M Panicek1, S D Go, J H Healey
1Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Radiology
|December 11, 1997
Summary
Magnetic resonance (MR) imaging findings of bone invasion in soft-tissue sarcoma predict poorer disease-specific survival. However, MR imaging of bone or neurovascular involvement is more useful for surgical planning than predicting recurrence or metastasis.
Area of Science:
- Radiology
- Oncology
- Surgical Pathology
Background:
- Soft-tissue sarcomas are malignant tumors requiring accurate prognostic indicators.
- Magnetic resonance (MR) imaging is crucial for evaluating tumor extent and involvement of critical structures.
- Predicting outcomes like recurrence, metastasis, and survival is vital for patient management.
Purpose of the Study:
- To assess if preoperative MR imaging findings of soft-tissue sarcoma involving bone or neurovascular structures can predict local recurrence, distant metastasis, or disease-specific survival.
- To correlate specific MR imaging features with patient outcomes.
Main Methods:
- Retrospective review of preoperative MR images from 46 soft-tissue sarcoma patients.
- Evaluation for tumor involvement of bone, major vessels, and major nerves.
- Correlation of MR imaging findings with post-surgical and post-treatment outcomes (local recurrence, distant metastasis, disease-specific survival).
Main Results:
- Bone invasion was observed in 26% of cases, major-vessel encasement in 11%, and major-nerve encasement in 15%.
- Patients with bone invasion had significantly higher rates of disease-related death (75% vs. 35%, P = .02).
- No significant differences in local recurrence, distant metastasis, or survival were found based on major-vessel or major-nerve encasement.
Conclusions:
- Bone invasion on preoperative MR imaging is a significant predictor of decreased disease-specific survival in soft-tissue sarcoma.
- While important for surgical planning, MR imaging findings of bone or neurovascular involvement do not reliably predict local recurrence, distant metastasis, or overall survival.